NOCT
NOCT (nocturnin, also known as CCR4L, Ccr4c, NOC and CCRN4L) is a circadian-regulated phosphatase that converts NADP(+) to NAD(+) and NADPH to NADH. It represses translation and promotes degradation of target mRNAs, linking the clock to metabolic gene control. Browse Assay Genie's current range of NOCT research reagents below, or read on for the biology behind the target.
NOCT is a phosphatase that catalyses the conversion of NADP(+) to NAD(+) and of NADPH to NADH, with a small preference for NADPH over NADP(+). Beyond this enzymatic activity, it represses translation and promotes degradation of target mRNA molecules. In this way nocturnin contributes to post-transcriptional regulation of metabolic genes that are under circadian control.
The NOCT gene encodes a 431-amino-acid protein that belongs to the CCR4/nocturin family. UniProt records it in the cytoplasm, nucleus, perinuclear region and mitochondrion. The protein shares similarity with the C-terminal domain of the yeast transcription factor carbon catabolite repression 4 (CCR4), which explains the earlier names CCR4-like and CCR4 carbon catabolite repression 4-like. Mouse and rat orthologs are both designated Noct.
The human gene is highly similar to nocturnin, first identified as a circadian clock-regulated gene in Xenopus laevis. The mRNA abundance of a similar mouse gene shows circadian rhythmicity, suggesting a role for the protein in clock function or as a circadian clock effector. NOCT exerts rhythmic post-transcriptional control of genes needed for nutrient absorption, glucose and insulin sensitivity, lipid metabolism, adipogenesis, inflammation and osteogenesis.
NOCT favours adipogenesis over osteoblastogenesis and is described as a key regulator of the balance between them. It promotes adipogenesis by facilitating nuclear translocation of PPARG, which activates its transcriptional activity. It also regulates circadian expression of NOS2 in the liver, negatively regulates circadian expression of IGF1 in bone, and is critical for proper development of early embryos.
NOCT is a circadian clock-regulated gene whose product may act in clock function or as a clock effector, making it relevant to rhythmic gene control.
NOCT regulates metabolic genes involved in nutrient absorption, glucose and insulin sensitivity and lipid metabolism, and converts NADPH to NADH.
NOCT regulates the adipogenesis/osteogenesis balance, promoting PPARG nuclear translocation and negatively regulating IGF1 expression in bone.
NOCT represses translation and promotes degradation of target mRNAs, offering a model for post-transcriptional control downstream of the circadian clock.
NOCT is a phosphatase that converts NADP(+) to NAD(+) and NADPH to NADH. It also represses translation and promotes degradation of target mRNAs, providing circadian post-transcriptional control of metabolic genes, and it promotes adipogenesis by facilitating PPARG nuclear translocation.
NOCT is also called nocturnin, CCR4L, Ccr4c, NOC and CCRN4L. Earlier names were CCR4-like and CCR4 carbon catabolite repression 4-like, reflecting similarity to the C-terminal domain of yeast CCR4. UniProt places it in the CCR4/nocturin family.
Yes. The human gene is highly similar to nocturnin, a circadian clock-regulated gene identified in Xenopus laevis, and mouse and rat carry orthologs named Noct. A similar mouse gene shows circadian mRNA rhythmicity. Check the datasheet of any product for its validated reactivity.
Pathway partners of NOCT in adipogenesis, circadian metabolic regulation and bone biology, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UK39; product specifications from Assay Genie datasheets.